Oncology
0 drugs are in development for Peritoneal Neoplasms.
- Companies
- 0
- Clinical trials
- 6
BioSniper AIPage evidence connected
Prepared research question
Which programs lead the Peritoneal Neoplasms pipeline—and what evidence could change the picture?
Run cited research
Traceable citations · Unknowns marked
About this indication
Peritoneal Neoplasms context
Oncology·MeSH: Peritoneal Neoplasms (D010534)
Also known as: Neoplasm, Peritoneal
Narrower concepts tracked separately: Peritoneal Carcinomatosis
Prevalence
3358.2 / 100K
Incidence
1547.2 / 100K/yr
Frequently asked questions
How many clinical trials target Peritoneal Neoplasms?
There are 6 clinical trials targeting Peritoneal Neoplasms tracked by BioSniper.
What is the prevalence of Peritoneal Neoplasms?
The estimated prevalence of Peritoneal Neoplasms is approximately 3358.2 per 100,000 population.